ビジネス · 2004/1/161 分で読めます
Notice of Approval of New Animal Drug Application; Ceftiofur
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is providing notice that it has approved a supplemental new animal drug application (NADA) filed by Pharmacia & Upjohn Co. The supplemental NADA provided revised susceptibility information for food-animal pathogens listed in the clinical microbiology section of labeling for ceftiofur hydrochloride injectable suspension.